CXCL12 and ovarian carcinoma: We used this imaging reporter to analyze CXCL12-CXCR4 signaling in ovarian cancer and establish that AMD3100, a small molecule inhibitor of CXCR4, blocks receptor activation in the tumor microenvironment.